
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Borderline forms of multiple sclerosis
Introduction
Overview
Overview
Idiopathic Inflammatory Demyelinating Diseases (IIDDs), sometimes known as Borderline forms of multiple sclerosis[1], is a collection of multiple sclerosis variants, sometimes considered different diseases[2].
Historical Perspective
Historical Perspective
Classification
Classification
Pathophysiology
Pathophysiology
Causes
Causes
Differentiating Idiopathic inflammatory Demyelinating Diseases from other Diseases
Differentiating Idiopathic inflammatory Demyelinating Diseases from other Diseases
The list of these diseases depends of the author, but usually are included:
- Optic-spinal MS and neuromyelitis optica (NMO or Devic’s disease), which are currently considered variants of the same condition.
- Acute disseminated encephalomyelitis or ADEM, a closely related disorder in which a known virus or vaccine triggers autoimmunity against myelin.
- Balo concentric sclerosis, a pathological form.
- Schilder disease or diffuse myelinoclastic sclerosis: is an infrequent disease that presents clinically as a pseudotumoural demyelinating lesion; and is more common in children.[3][4]
- Marburg multiple sclerosis, pathological form, also known as malignant, fulminant or acute MS.
As MS is an active field for research, the list is not closed or definitive. For example, some diseases like Susac’s syndrome (MS has an important vascular component [5]) or autoimmune variants of peripheral neuropathies like Guillain-BarrΓ© syndrome could be included.
Some authors also think that primary progressive multiple sclerosis should be considered a different entity from standard MS[6] [7]. Others maintain the opposite[8].
Finally, also a dual classification of these diseases has been proposed, according to the shape of edges of the scars, in MS-like and ADEM-like[9]
Epidemiology and Demographics
Epidemiology and Demographics
Age
Gender
Race
Risk Factors
Risk Factors
Natural History, Complications and Prognosis
Natural History, Complications and Prognosis
Diagnosis
Diagnosis
Diagnostic Criteria
Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Treatment
Medical Therapy
Surgery
Prevention
References
References
- β “[Borderline forms of multiple sclerosis]”. Rev. Neurol. (Paris) (in French). 157 (8-9 Pt 2): 929β34. 2001. PMIDΒ 11787357. Unknown parameter
|autho=ignored (help) - β Wingerchuk DM, Lucchinetti CF (2007). “Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis”. Curr. Opin. Neurol. 20 (3): 343β50. doi:10.1097/WCO.0b013e3280be58d8. PMIDΒ 17495631.
- β Garrido C, Levy-Gomes A, Teixeira J, Temudo T (2004). “[Schilder’s disease: two new cases and a review of the literature]”. Revista de neurologia (in Spanish). 39 (8): 734β8. PMIDΒ 15514902.
- β Afifi AK, Bell WE, Menezes AH, Moore SA (1994). “Myelinoclastic diffuse sclerosis (Schilder’s disease): report of a case and review of the literature”. J. Child Neurol. 9 (4): 398β403. PMIDΒ 7822732.
- β Minagar A, Jy W, Jimenez JJ, Alexander JS (2006). “Multiple sclerosis as a vascular disease”. Neurol. Res. 28 (3): 230β5. PMIDΒ 16687046.
- β Vukusic S, Confavreux C (2003). “Primary and secondary progressive multiple sclerosis”. J. Neurol. Sci. 206 (2): 153β5. PMIDΒ 12559503.
- β IDressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F (2006). “Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis”. Acta Neurol. Scand. 114 (6): 368β73. PMIDΒ 17083335.
- β Ebers GC (2004). “Natural history of primary progressive multiple sclerosis”. Mult. Scler. 10 Suppl 1: S8β13, discussion S13-5. PMIDΒ 15218804.
- β Poser CM, Brinar VV (2004). “The nature of multiple sclerosis”. Clinical neurology and neurosurgery. 106 (3): 159β71. PMIDΒ 15177764.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
